LON:LABS Life Science REIT (LABS) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Life Science REIT Stock (LON:LABS) Get Life Science REIT alerts:Sign Up Key Stats Today's Range N/A50-Day Range 43.10▼ 43.1052-Week Range N/AVolumeN/AAverage Volume3.84 million shsMarket Capitalization£150.85 millionP/E RatioN/ADividend Yield5.67%Price TargetN/AConsensus RatingN/A Company Overview Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange. The registered office of the Company is located at 6th Floor, 65 Gresham Street, London, EC2V 7NQ. Read More Receive LABS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Life Science REIT and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LABS Stock News HeadlinesLife Science REIT Appoints New Senior Independent DirectorDecember 3, 2025 | tipranks.comSee More Headlines LABS Stock Analysis - Frequently Asked Questions How were Life Science REIT's earnings last quarter? Life Science REIT plc (LON:LABS) released its quarterly earnings results on Tuesday, September, 23rd. The company reported ($8.50) earnings per share for the quarter. Life Science REIT had a negative net margin of 68.83% and a negative trailing twelve-month return on equity of 5.11%. Company Calendar Last Earnings9/23/2025Today10/24/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorReal Estate Industry Healthcare REITs Sub-IndustryHealthcare REITs Current SymbolLON:LABS CIKN/A Webwww.lifesciencereit.co.uk Phone44-20-7945-9566FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (8.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£40.62 million Net Margins-68.83% Pretax MarginN/A Return on Equity-5.11% Return on Assets1.25% Debt Debt-to-Equity Ratio46.52 Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales-£22.01 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 76.35 per share Price / BookN/AMiscellaneous Outstanding Shares350,000,000Free FloatN/AMarket Cap£150.85 million OptionableNot Optionable Beta0.08 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (LON:LABS) was last updated on 4/20/2026 by MarketBeat.com Staff. From Our PartnersHow I’m playing the AI melt-up (and down)Porter Stansberry says a powerful new market shift is forming and most investors are missing it entirely. I...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | Sponsored$29.97 or $0 todayThe 0DTE Game Plan normally sells for 29.97, but it is free today through this link. Inside is a straightfo...Profits Run | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Life Science REIT plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Life Science REIT With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
